Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Thirunavukkarasu Sathish; Robyn Tapp; Mark E.  Cooper; Paul  Zimmet

doi:10.1016/j.diabet.2020.10.002

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Thirunavukkarasu Sathish, Robyn Tapp, Mark E. Cooper, Paul Zimmet

Research output: Contribution to journal › Comment/debate › peer-review

73 Citations (Scopus)

Abstract

The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.

Original language	English
Article number	101204
Journal	Diabetes and Metabolism
Volume	47
Issue number	2
Early online date	28 Oct 2020
DOIs	https://doi.org/10.1016/j.diabet.2020.10.002
Publication status	Published - Mar 2021

Keywords

COVID-19
Coronavirus
Incident diabetes
Inflammation
Insulin resistance
Insulin secretion
New-onset diabetes
Metabolism
Type 1 diabetes
Type 2 diabetes

ASJC Scopus subject areas

Endocrinology
Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.diabet.2020.10.002

Cite this

@article{d461ca8cddbb49158c1d2afacde8c79a,

title = "Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes",

abstract = "The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.",

keywords = "COVID-19, Coronavirus, Incident diabetes, Inflammation, Insulin resistance, Insulin secretion, New-onset diabetes, Metabolism, Type 1 diabetes, Type 2 diabetes",

author = "Thirunavukkarasu Sathish and Robyn Tapp and Cooper, {Mark E.} and Paul Zimmet",

year = "2021",

month = mar,

doi = "10.1016/j.diabet.2020.10.002",

language = "English",

volume = "47",

journal = "Diabetes and Metabolism",

issn = "1878-1780",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

AU - Sathish, Thirunavukkarasu

AU - Tapp, Robyn

AU - Cooper, Mark E.

AU - Zimmet, Paul

PY - 2021/3

Y1 - 2021/3

N2 - The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.

AB - The pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is rapidly evolving worldwide and is now face-to-face with another major pandemic ― diabetes mellitus.

KW - COVID-19

KW - Coronavirus

KW - Incident diabetes

KW - Inflammation

KW - Insulin resistance

KW - Insulin secretion

KW - New-onset diabetes

KW - Metabolism

KW - Type 1 diabetes

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85102307465&partnerID=8YFLogxK

U2 - 10.1016/j.diabet.2020.10.002

DO - 10.1016/j.diabet.2020.10.002

M3 - Comment/debate

SN - 1878-1780

VL - 47

JO - Diabetes and Metabolism

JF - Diabetes and Metabolism

IS - 2

M1 - 101204

ER -

Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this